Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.5 MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
21 food elimination diet----[1] 98 💬
31 food elimination diet therapy----[1] 98 💬
41 MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
51MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
62MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
74 food elimination diet----[1] 98 💬
85 MG montelukast[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬 		[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 98 💬
96 food elimination diet therapy----[1] 98 💬
10AK002----[1] 98 💬
11Alpha-proteinase inhibitor----[1] 98 💬
12AMG 157[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
13AMG157----[1] 98 💬
14Antigen (wheat base SOY sauce) spray----[1] 98 💬
15APD334----[5] 93, 96, 97, 98, 269 💬
16APT-1011----[1] 98 💬
17APT-1011 - 3 MG----[1] 98 💬
18APT-1011 3 MG HS----[1] 98 💬
19AQ280----[1] 98 💬
20AR401959 L-arginine----[3] 96, 97, 98 💬
21Assessment OF medication compliance----[1] 98 💬
22Baked milk----[1] 98 💬
23Barium esophagram[1] Barium---[1] 98 💬
24Barzolvolimab[1] Barzolvolimab[1] Barzolvolimab 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[1] 98 💬
25Beclomethasone dipropionate[1] Beclomethasone dipropionate[3] Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
26Benralizumab[1] Benralizumab[1] Benralizumab 💬 [1] IL5RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299 💬
27Bethanechol[1] Bethanechol[1] Bethanechol chloride 💬 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 98 💬
28Blood sampling----[9] 13, 17, 46, 49, 51, 96, 98, 106, 162 💬
29Bone mineral density (dexa) scan----[1] 98 💬
30BT-11 high----[1] 98 💬
31BT-11 LOW----[1] 98 💬
32Budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[7] 66, 93, 94, 95, 96, 97, 98 💬
33Budesonide 0.5 MG compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
34Budesonide 0.5 MG orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
35Budesonide 0.5MG orodispersible tablet twice daily[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
36Budesonide 1 MG compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
37Budesonide 1 MG orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
38Budesonide 1MG orodispersible tablet twice daily[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
39Budesonide [0.4MG/ML] viscous suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
40Budesonide GEL[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
41Budesonide oral suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42Budesonide plus prevacid[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
43Buet 0.5 MG----[1] 98 💬
44Buet 1 MG----[1] 98 💬
45Buet 1MG----[1] 98 💬
46Buet 2MG----[1] 98 💬
47BUL 0.5 MG----[1] 98 💬
48BUL 1 MG----[1] 98 💬
49BUU 0.4MG/ML----[1] 98 💬
50CALY-002[1] CALY-002---[1] 98 💬
51CC-93538----[1] 98 💬
52CDX-0159----[1] 98 💬
53Cendakimab[1] Cendakimab[1] Cendakimab 💬 [1] IL13 💬 [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬[1] 98 💬
54Citalopram[1] Citalopram[2] Citalopram hydrobromide ,
Citalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[5] 6, 13, 46, 98, 127 💬
55Compressa effervescente 0,5 MG DI budesonide PER USO orodispersibile[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
56Compressa effervescente 1 MG DI budesonide PER USO orodispersibile[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
57Computerized tomography scan----[1] 98 💬
58Cortisol level[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
59CYP substrates----[1] 98 💬
60D-xylose----[1] 98 💬
61Dexlansoprazole[1] Dexlansoprazole[2] Dexlansoprazole ,
Dexlansoprazole sesquihydrate 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
62Dose----[1] 98 💬
63Dupilumab[1] Dupilumab[1] Dupilumab 💬 [1] IL4R 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[5] 51, 97, 98, 160, 162 💬
64Dupixent[1] Dupilumab[1] Dupilumab 💬 [1] IL4R 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[3] 98, 160, 162 💬
65Elimination diet----[1] 98 💬
66Else nutrition formula----[1] 98 💬
67Endoscopy while ON study drug----[1] 98 💬
68Eosinophilic esophagitis (E0E) food introduction-2ND----[1] 98 💬
69Eosinophilic esophagitis (EOE) food introduction-1ST----[1] 98 💬
70Eosinophilic esophagitis (EOE) food introduction-3RD dose----[1] 98 💬
71EP-104IAR----[1] 98 💬
72ESO-101----[1] 98 💬
73Esomeprazole[1] Esomeprazole[5] Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[9] 6, 13, 46, 86, 98, 107, 113, 298, 299 💬
74Esophacap----[1] 98 💬
75Esophageal barium xray----[1] 98 💬
76Esophageal biopsies----[1] 98 💬
77Esophageal dilation----[1] 98 💬
78Esophagogastroduodenoscopy----[1] 98 💬
79Etrasimod[1] Etrasimod[2] Etrasimod ,
Etrasimod arginine 💬 		[3] S1PR1,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 96, 97, 98 💬
80Etrasimod L-arginine[1] Etrasimod[2] Etrasimod ,
Etrasimod arginine 💬 		[3] S1PR1,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 96, 97, 98 💬
81EUR-1100----[1] 98 💬
82Famotidine[1] Famotidine[1] Famotidine 💬 [1] HRH2 💬 [4] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 6, 46, 98, 145, 300 💬
83Fasenra[1] Benralizumab[1] Benralizumab 💬 [1] IL5RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299 💬
84Florence 30 µG/ML----[1] 98 💬
85Florence 60 µG/ML----[1] 98 💬
86Florence 90 µG/ML----[1] 98 💬
87Flovent----[1] 98 💬
88Fluticasone[1] Fluticasone[1] Fluticasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 98, 228, 299 💬
89Fluticasone MDI[1] Fluticasone[1] Fluticasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
90Fluticasone propionate[2] Fluticasone,
Fluticasone propionate		[2] Fluticasone propionate ,
Fluticasone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 98, 228, 306 💬
91Fluticasone propionate, USP[2] Fluticasone,
Fluticasone propionate		[2] Fluticasone propionate ,
Fluticasone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
92Formalin-fixed paraffin-embedded (ffpe) tissue samples analysis[1] Formaldehyde[1] Formaldehyde 💬 --[1] 98 💬
93Gastrointestinal quality OF life index----[1] 98 💬
94Height measurement----[1] 98 💬
95High dose budesonide suspension----[1] 98 💬
96High dose budesonide tablet----[1] 98 💬
97HIGH-resolution manometry----[1] 98 💬
98Honey[1] Honey[1] Honey 💬 --[3] 57, 98, 230 💬
99Humanised IGG1K monoclonal antibody against KIT----[1] 98 💬
100Infliximab[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[24] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 164, 269, 270, 271 💬
101Inhaled/swallowed budesonide----[1] 98 💬
102Intraluminal impedance----[1] 98 💬
103IRL201104----[1] 98 💬
104Jorveza[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
105Jorveza 0.5 MG compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
106Jorveza 0.5 MG orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
107Jorveza 1 MG compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
108Jorveza 1 MG orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
109Lirentelimab[1] Lirentelimab[1] Lirentelimab 💬 --[1] 98 💬
110Loratadine[1] Loratadine[1] Loratadine 💬 [1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 13, 19, 46, 89, 98 💬
111Losartan potassium[1] Losartan[2] Losartan potassium ,
Losartan 💬 		[1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[5] 36, 98, 167, 179, 215 💬
112LOW dose budesonide tablet----[1] 98 💬
113MEDI-563----[5] 44, 45, 98, 162, 299 💬
114MEDI9929[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
115Medication compliance phone call----[1] 98 💬
116Mepolizumab[1] Mepolizumab[1] Mepolizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[4] 44, 45, 98, 162 💬
117Mepolizumab 100 MG[1] Mepolizumab[1] Mepolizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[1] 98 💬
118Mepolizumab 300 MG[1] Mepolizumab[1] Mepolizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[1] 98 💬
119Mesalamine oral product[1] Mesalazine[1] Mesalamine 💬 --[1] 98 💬
120Mometasone furoate[2] Mometasone,
Mometasone furoate		[3] Mometasone furoate ,
Mometasone furoate hydrate ,
Mometasone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 98, 162 💬
121Montelukast[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬 		[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[9] 6, 13, 19, 46, 61, 63, 85, 98, 228 💬
122Montelukast/ singulair[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬 		[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 98 💬
123Nasonex----[1] 98 💬
124NDX-3315 and NDX-3324[1] NDX-3315---[1] 98 💬
125Niox mino® airway inflammation monitor----[1] 98 💬
126OC000459----[1] 98 💬
127Omalizumab[1] Omalizumab[1] Omalizumab 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[7] 46, 53, 65, 98, 162, 226, 299 💬
128Omeprazole[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[12] 6, 13, 21, 46, 85, 90, 96, 97, 98, 271, 282, 298 💬
129Omeprazole 20 MG oral tablet[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
130Omeprazole 20MG BID[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
131Ondansetron[1] Ondansetron[2] Ondansetron ,
Ondansetron hydrochloride hydrate 💬 		[5] HTR3,
HTR3,
HTR3,
HTR3,
HTR3 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬[3] 98, 107, 231 💬
132Oral budesonide----[2] 97, 98 💬
133Oral cromolyn sodium----[1] 98 💬
134Oral nitric oxide testing----[1] 98 💬
135Oral viscous budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
136Physical examination and questionnaires----[1] 98 💬
137Planar images----[1] 98 💬
138Propofol[1] Propofol[1] Propofol 💬 [16] GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		[8] GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[10] 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
139QAX576----[4] 51, 85, 96, 98 💬
140Reslizumab[1] Reslizumab[1] Reslizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[2] 44, 98 💬
141Retrospective evaluation OF endoscopy prior TO study drug----[1] 98 💬
142RPC4046----[1] 98 💬
143Saline[1] Sodium chloride[1] Sodium chloride 💬 --[19] 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
144SB-240563----[3] 44, 45, 98 💬
145SCH55700----[1] 98 💬
146Serum biomarkers----[1] 98 💬
147Sevoflurane[1] Sevoflurane[1] Sevoflurane 💬 --[8] 6, 21, 22, 34, 70, 98, 225, 296 💬
148Single photon emission computed tomography scans----[1] 98 💬
149Sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [49] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[39] 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
150SIX-foods elimination diet----[1] 98 💬
151Solrikitug high dose[1] Solrikitug[1] Solrikitug 💬 [1] TSLPR 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
152Solrikitug LOW dose[1] Solrikitug[1] Solrikitug 💬 [1] TSLPR 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
153Solrikitug MID dose[1] Solrikitug[1] Solrikitug 💬 [1] TSLPR 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
154Steroid and proton pump inhibitor therapy----[1] 98 💬
155Stool sampling----[1] 98 💬
156Sucralfate[1] Sucralfate[1] Sucralfate 💬 --[1] 98 💬
157Swallowed fluticasone----[1] 98 💬
158Symptom survey----[1] 98 💬
159Technetium TC 99M[1] Technetium Tc-99m---[1] 98 💬
160Tezepelumab[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[3] 44, 45, 98 💬
161Tezepelumab apfs[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
162Tezepelumab VIA apfs[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
163Treat with lansoprazole 30 MG BID FOR 2 weeks, endoscopic examination with esophageal biopsy FOR patients with persistent symptoms----[1] 98 💬
164Unstimulated saliva sampling----[1] 98 💬
165Urine sampling----[1] 98 💬
166Viaskin milk 500 MCG----[1] 98 💬
167Viscous/swallowed budesonide----[1] 98 💬
168Vitamin D measurement[1] Vitamin D---[1] 98 💬
169Vonoprazan[1] Vonoprazan[1] Vonoprazan 💬 [2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[3] 63, 97, 98 💬
170Xanthan GUM[1] Xanthan gum[1] Xanthan gum 💬 --[1] 98 💬
171Zofran - NO intubation----[1] 98 💬